Chyi-Hung Hsu
Director at J&J PRD
📍 Mendham, New Jersey, United States
Chyi-Hung Hsu, PhD, is a Director at Johnson & Johnsons Janssen R&D, specializing in statistical methodology for clinical drug development. His expertise covers pharmacokinetic/pharmacodynamic (PK/PD) modeling, Bayesian approaches, and adaptive trial designs to improve the efficiency of assessing drug efficacy and safety.
He applies advanced Bayesian statistical methods to pediatric pharmacokinetic studies, helping to improve drug development for children.
Read the full overview →Current Role
Director
Job Level
Mid-senior
Location
Mendham, New Jersey, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Chyi-Hung cares about
PK/PD Modeling
His research focuses on pharmacokinetic and pharmacodynamic models to assess drug efficacy, dosing regimens, and exposure-response relationships in clinical trials.
Bayesian Methods
He specializes in applying Bayesian approaches to clinical trial design and subgroup analysis to enhance the efficiency and accuracy of drug development.
Career
Work history
Director
J&J PRD
Sr. Expert Stats Methodologist
Novartis
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Education
Chyi-Hung has no verified education history
Social presence
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.